Overview

The Effect of Micro-doses Erytropoietin on Exercise Capacity in Male and Females

Status:
Active, not recruiting
Trial end date:
2022-12-01
Target enrollment:
0
Participant gender:
All
Summary
Recombinant human erythropoietin (rHuEPO) regimen enhances maximal oxygen consumption (VO2max), but the effect of micro-doses on maximal and submaximal performance is not clear and detection of micro-doses is difficult with current methods. This study investigated whether micro-doses of rHuEPO enhances maximal and endurance performance in males and females.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Copenhagen
Criteria
Inclusion Criteria:

- Relative maximum oxygen uptake (VO2-max) of at least 50 ml O2/min/kg for male
participants and 45 ml O2/min/kg for female participants

Exclusion Criteria:

- Age

- Insufficient fitness level

- Blood donation 3 months prior to enrollment

- Altitude exposure 2 months before enrollment

- Hypertension